BACKGROUND: There are relatively few data on the genetic spectrum of Chinese frontotemporal dementia (FTD) population. OBJECTIVE: With the dementia cohort of Peking Union Medical College Hospital, we aim to illustrate the genetic spectrum of FTD patients, as well as the phenotypic heterogeneity of FTD-gene variant carriers. METHODS: 204 unrelated, clinically diagnosed FTD patients of Chinese ancestry were enrolled. All the participants received demographic survey, history inquiry, physical examination, cognitive assessment, blood biochemical test, brain CT/MRI, and gene sequencing. RESULTS: 56.4% (115/204) participants were clinically diagnosed with behavioral variant of FTD, 20.6% (42/204) with nonfluent/agrammatic variant primary progressive aphasia (PPA), 20.1% (41/204) with semantic variant PPA, and 2.9% (6/204) with mixed variant PPA. 11.8% (24/204) subjects harbored the potential causative variants in FTD-related genes, including the MAPT (n = 7), TBK1 (n = 7), GRN (n = 2), TBK1+GRN (n = 1), VCP (n = 1), TARDBP (n = 1), UBQLN2 (n = 1), SQSTM1 (n = 1), DCTN1 (n = 1), HNRNPA1 (n = 1), and C9orf72 GGGGCC repeats (n = 1). The TBK1 T31fs, T457fs, K622fs, c.359-1G>A, the VCP P188T, and the GRN P50fs, P439fs were novel pathogenic/likely pathogenic variants. The TBK1 carriers showed a later disease onset and a higher incidence of parietal atrophy relative to the MAPTcarriers. CONCLUSION: There is genetic and clinical heterogeneity among Chinese FTD population. The TBK1 has a high mutation frequency in Chinese FTD patients.
BACKGROUND: There are relatively few data on the genetic spectrum of Chinese frontotemporal dementia (FTD) population. OBJECTIVE: With the dementia cohort of Peking Union Medical College Hospital, we aim to illustrate the genetic spectrum of FTD patients, as well as the phenotypic heterogeneity of FTD-gene variant carriers. METHODS: 204 unrelated, clinically diagnosed FTD patients of Chinese ancestry were enrolled. All the participants received demographic survey, history inquiry, physical examination, cognitive assessment, blood biochemical test, brain CT/MRI, and gene sequencing. RESULTS: 56.4% (115/204) participants were clinically diagnosed with behavioral variant of FTD, 20.6% (42/204) with nonfluent/agrammatic variant primary progressive aphasia (PPA), 20.1% (41/204) with semantic variant PPA, and 2.9% (6/204) with mixed variant PPA. 11.8% (24/204) subjects harbored the potential causative variants in FTD-related genes, including the MAPT (n = 7), TBK1 (n = 7), GRN (n = 2), TBK1+GRN (n = 1), VCP (n = 1), TARDBP (n = 1), UBQLN2 (n = 1), SQSTM1 (n = 1), DCTN1 (n = 1), HNRNPA1 (n = 1), and C9orf72 GGGGCC repeats (n = 1). The TBK1 T31fs, T457fs, K622fs, c.359-1G>A, the VCP P188T, and the GRN P50fs, P439fs were novel pathogenic/likely pathogenic variants. The TBK1 carriers showed a later disease onset and a higher incidence of parietal atrophy relative to the MAPTcarriers. CONCLUSION: There is genetic and clinical heterogeneity among Chinese FTD population. The TBK1 has a high mutation frequency in Chinese FTD patients.
Authors: M L Gorno-Tempini; A E Hillis; S Weintraub; A Kertesz; M Mendez; S F Cappa; J M Ogar; J D Rohrer; S Black; B F Boeve; F Manes; N F Dronkers; R Vandenberghe; K Rascovsky; K Patterson; B L Miller; D S Knopman; J R Hodges; M M Mesulam; M Grossman Journal: Neurology Date: 2011-02-16 Impact factor: 9.910
Authors: Katya Rascovsky; John R Hodges; David Knopman; Mario F Mendez; Joel H Kramer; John Neuhaus; John C van Swieten; Harro Seelaar; Elise G P Dopper; Chiadi U Onyike; Argye E Hillis; Keith A Josephs; Bradley F Boeve; Andrew Kertesz; William W Seeley; Katherine P Rankin; Julene K Johnson; Maria-Luisa Gorno-Tempini; Howard Rosen; Caroline E Prioleau-Latham; Albert Lee; Christopher M Kipps; Patricia Lillo; Olivier Piguet; Jonathan D Rohrer; Martin N Rossor; Jason D Warren; Nick C Fox; Douglas Galasko; David P Salmon; Sandra E Black; Marsel Mesulam; Sandra Weintraub; Brad C Dickerson; Janine Diehl-Schmid; Florence Pasquier; Vincent Deramecourt; Florence Lebert; Yolande Pijnenburg; Tiffany W Chow; Facundo Manes; Jordan Grafman; Stefano F Cappa; Morris Freedman; Murray Grossman; Bruce L Miller Journal: Brain Date: 2011-08-02 Impact factor: 13.501
Authors: Rita Guerreiro; Owen A Ross; Celia Kun-Rodrigues; Dena G Hernandez; Tatiana Orme; John D Eicher; Claire E Shepherd; Laura Parkkinen; Lee Darwent; Michael G Heckman; Sonja W Scholz; Juan C Troncoso; Olga Pletnikova; Olaf Ansorge; Jordi Clarimon; Alberto Lleo; Estrella Morenas-Rodriguez; Lorraine Clark; Lawrence S Honig; Karen Marder; Afina Lemstra; Ekaterina Rogaeva; Peter St George-Hyslop; Elisabet Londos; Henrik Zetterberg; Imelda Barber; Anne Braae; Kristelle Brown; Kevin Morgan; Claire Troakes; Safa Al-Sarraj; Tammaryn Lashley; Janice Holton; Yaroslau Compta; Vivianna Van Deerlin; Geidy E Serrano; Thomas G Beach; Suzanne Lesage; Douglas Galasko; Eliezer Masliah; Isabel Santana; Pau Pastor; Monica Diez-Fairen; Miquel Aguilar; Pentti J Tienari; Liisa Myllykangas; Minna Oinas; Tamas Revesz; Andrew Lees; Brad F Boeve; Ronald C Petersen; Tanis J Ferman; Valentina Escott-Price; Neill Graff-Radford; Nigel J Cairns; John C Morris; Stuart Pickering-Brown; David Mann; Glenda M Halliday; John Hardy; John Q Trojanowski; Dennis W Dickson; Andrew Singleton; David J Stone; Jose Bras Journal: Lancet Neurol Date: 2017-12-16 Impact factor: 44.182
Authors: Daniela Galimberti; Bernardo Dell'Osso; Chiara Fenoglio; Chiara Villa; Francesca Cortini; Maria Serpente; Sarah Kittel-Schneider; Johannes Weigl; Maria Neuner; Juliane Volkert; C Leonhard; David G Olmes; Juliane Kopf; Claudia Cantoni; Elisa Ridolfi; Carlotta Palazzo; Laura Ghezzi; Nereo Bresolin; A C Altamura; Elio Scarpini; Andreas Reif Journal: PLoS One Date: 2012-04-10 Impact factor: 3.240
Authors: Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm Journal: Genet Med Date: 2015-03-05 Impact factor: 8.822
Authors: Julie van der Zee; Ilse Gijselinck; Sara Van Mossevelde; Federica Perrone; Lubina Dillen; Bavo Heeman; Veerle Bäumer; Sebastiaan Engelborghs; Jan De Bleecker; Jonathan Baets; Ellen Gelpi; Ricardo Rojas-García; Jordi Clarimón; Alberto Lleó; Janine Diehl-Schmid; Panagiotis Alexopoulos; Robert Perneczky; Matthis Synofzik; Jennifer Just; Ludger Schöls; Caroline Graff; Håkan Thonberg; Barbara Borroni; Alessandro Padovani; Albena Jordanova; Stayko Sarafov; Ivailo Tournev; Alexandre de Mendonça; Gabriel Miltenberger-Miltényi; Frederico Simões do Couto; Alfredo Ramirez; Frank Jessen; Michael T Heneka; Estrella Gómez-Tortosa; Adrian Danek; Patrick Cras; Rik Vandenberghe; Peter De Jonghe; Peter P De Deyn; Kristel Sleegers; Marc Cruts; Christine Van Broeckhoven; Johan Goeman; Dirk Nuytten; Katrien Smets; Wim Robberecht; Philip Van Damme; Jan De Bleecker; Patrick Santens; Bart Dermaut; Jan Versijpt; Alex Michotte; Adrian Ivanoiu; Olivier Deryck; Bruno Bergmans; Jean Delbeck; Marc Bruyland; Christiana Willems; Eric Salmon; Pau Pastor; Sara Ortega-Cubero; Luisa Benussi; Roberta Ghidoni; Giuliano Binetti; Isabel Hernández; Mercè Boada; Agustín Ruiz; Sandro Sorbi; Benedetta Nacmias; Silvia Bagnoli; Sandro Sorbi; Raquel Sanchez-Valle; Albert Llado; Isabel Santana; Maria Rosário Almeida; Giovanni B Frisoni; Walter Maetzler; Radoslav Matej; Matthew J Fraidakis; Gabor G Kovacs; Gian Maria Fabrizi; Silvia Testi Journal: Hum Mutat Date: 2017-01-19 Impact factor: 4.878
Authors: Hulya Ulugut; Simone Stek; Lianne E E Wagemans; Roos J Jutten; Maria Antoinette Keulen; Femke H Bouwman; Niels D Prins; Afina W Lemstra; Welmoed Krudop; Charlotte E Teunissen; Bart N M van Berckel; Rik Ossenkoppele; Frederik Barkhof; Wiesje M van der Flier; Philip Scheltens; Yolande A L Pijnenburg Journal: J Neurol Date: 2021-07-03 Impact factor: 4.849